JP2001514655A5 - - Google Patents

Download PDF

Info

Publication number
JP2001514655A5
JP2001514655A5 JP1998539619A JP53961998A JP2001514655A5 JP 2001514655 A5 JP2001514655 A5 JP 2001514655A5 JP 1998539619 A JP1998539619 A JP 1998539619A JP 53961998 A JP53961998 A JP 53961998A JP 2001514655 A5 JP2001514655 A5 JP 2001514655A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1998539619A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001514655A (ja
Filing date
Publication date
Priority claimed from US08/814,490 external-priority patent/US6160018A/en
Application filed filed Critical
Priority claimed from PCT/US1998/004176 external-priority patent/WO1998040061A1/en
Publication of JP2001514655A publication Critical patent/JP2001514655A/ja
Publication of JP2001514655A5 publication Critical patent/JP2001514655A5/ja
Pending legal-status Critical Current

Links

JP53961998A 1997-03-10 1998-03-04 アルツハイマー病予防へのr−nsaid’sの利用 Pending JP2001514655A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/814,490 US6160018A (en) 1995-03-13 1997-03-10 Prophylactic composition and method for alzheimer's Disease
US08/814,490 1997-03-10
PCT/US1998/004176 WO1998040061A1 (en) 1997-03-10 1998-03-04 Use of r-nsaid's for the prevention of alzheimer's disease

Publications (2)

Publication Number Publication Date
JP2001514655A JP2001514655A (ja) 2001-09-11
JP2001514655A5 true JP2001514655A5 (enExample) 2005-01-13

Family

ID=25215202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53961998A Pending JP2001514655A (ja) 1997-03-10 1998-03-04 アルツハイマー病予防へのr−nsaid’sの利用

Country Status (9)

Country Link
EP (2) EP0966277B1 (enExample)
JP (1) JP2001514655A (enExample)
AT (2) ATE311865T1 (enExample)
AU (1) AU6682298A (enExample)
CA (1) CA2283255C (enExample)
DE (2) DE69832695T2 (enExample)
DK (1) DK0966277T3 (enExample)
ES (1) ES2253810T3 (enExample)
WO (1) WO1998040061A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2163986B1 (es) * 1999-07-13 2003-02-16 Menarini Lab Acidos-alfa-arilpropionicos y arilaceticos como inhibidores de la ciclooxigenasa-ii.
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
EP1558268A4 (en) * 2002-09-17 2008-09-17 Univ New York METHODS FOR TREATING AGE-RELATED MEMORY ALTERATIONS (AAMI), LIGHT COGNITIVE DEFICITS (MCI) AND DEMENTIA USING CELL CYCLE INHIBITORS
EP1551384A4 (en) * 2002-10-07 2008-04-09 Encore Pharmaceuticals Inc R-NSAID ESTERS AND ITS USE
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
WO2005065069A2 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
US8110681B2 (en) * 2006-03-17 2012-02-07 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compounds for the treatment of spinal muscular atrophy and other uses
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
WO2008034244A1 (en) * 2006-09-21 2008-03-27 Waratah Pharmaceuticals Inc. The combination of a cyclohexanehexol and a nsaid for the treatment of neurodegenerative diseases
WO2008149181A1 (en) 2007-06-04 2008-12-11 Techfields Inc Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
WO2010065936A1 (en) 2008-12-04 2010-06-10 Chongxi Yu High penetration compositions and their applications
CN104540504A (zh) 2012-01-18 2015-04-22 苏州泰飞尔医药有限公司 治疗肺部疾病的高穿透力前药组合物和医药组合物
EP3022560B1 (en) 2013-07-11 2020-09-02 University of North Texas Health Science Center at Fort Worth Blood-based screen for detecting neurological diseases in primary care settings
JP6364488B2 (ja) 2013-11-26 2018-07-25 ユニバーシティー オブ ノース テキサス ヘルス サイエンス センター アット フォートワースUniversity Of North Texas Health Science Center At Fort Worth 認知欠損を治療するための個別化医療的手法
AU2019209792B2 (en) * 2018-01-18 2025-08-14 University Of North Texas Health Science Center At Fort Worth Companion diagnostic for NSAIDs and donepezil for treating specific subpopulations of patients suffering from alzheimer's disease
US20230038360A1 (en) * 2019-12-20 2023-02-09 Basf Se Composition for the treatment of amyloid-beta associated diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
US5192753A (en) * 1991-04-23 1993-03-09 Mcgeer Patrick L Anti-rheumatoid arthritic drugs in the treatment of dementia
FR2687915B1 (fr) * 1992-02-28 1995-05-05 Rhone Poulenc Rorer Sa Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r).
US5331000A (en) * 1992-03-09 1994-07-19 Sepracor Inc. Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac
US6160018A (en) * 1995-03-13 2000-12-12 Loma Linda University Medical Center Prophylactic composition and method for alzheimer's Disease
US5955504A (en) * 1995-03-13 1999-09-21 Loma Linda University Medical Center Colorectal chemoprotective composition and method of preventing colorectal cancer
AU3641597A (en) * 1996-06-21 1998-01-07 Advanced Research And Technology Institute, Inc. Methods and compositions comprising r-ibuprofen

Similar Documents

Publication Publication Date Title
JP2000509635A5 (enExample)
JP2000509912A5 (enExample)
JP2000509637A5 (enExample)
JP2000507042A5 (enExample)
JP2000510751A5 (enExample)
JP2000509942A5 (enExample)
JP2000509587A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2000508022A5 (enExample)
JP2000508841A5 (enExample)
JP2000508680A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2000509755A5 (enExample)
JP2000510247A5 (enExample)
JP2000510969A5 (enExample)
JP2000508836A5 (enExample)
JP2000508102A5 (enExample)
JP2000509818A5 (enExample)
JP2000509520A5 (enExample)
JP2000507434A5 (enExample)
JP2001514655A5 (enExample)